PPARD and melanoma: Employing B16 melanoma and LLC1 (Lewis lung carcinoma) tumor cell inoculated in PPARβ/δ−/− mice, Müller-Brüsselbach and colleagues demonstrated cancer vascularization defects and diminished tumor blood flow, resulting in reduced tumor growth in animals lacking PPARβ/δ.